Topics

Companies Related to "Determine the Association Between the Level of SCI With Chronic Respiratory Symptoms, Measures of Pulmonary Function, and Respiratory Illness." [Most Relevant Company Matches] RSS

22:58 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "Determine the Association Between the Level of SCI With Chronic Respiratory Symptoms, Measures of Pulmonary Function, and Respiratory Illness." found in our extensive corporate database of over 50,000 company records.

Showing "Determine Association Between Level With Chronic Respiratory Symptoms" Companies 1–25 of 4,000+

Relevant

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases. Pulmatrix’s lead proprietary therapies, called inhaled cationic airway lining modulators (iCALM™), are a novel approach to prevent and treat acute exacerbations an...


The Campaign to End Chronic Pain in Women

The Campaign to End Chronic Pain in Women is an advocacy campaign fighting to end discrimination and improve care for women suffering from chronic pain. The Campaign is made up of volunteer leaders from the CFIDS Association of America, Endometriosis Association, National Vulvodynia Association, and The TMJ Association. For more information, visit www.EndWomensPain.org.

Pulmatrix

Pulmatrix is discovering and developing a new class of therapies --inhaled cationic airway lining modulators (iCALM) –to prevent and treat respiratory infections and acute exacerbations of chronic respiratory diseases. iCALM therapies have broad potential to treat and prevent a wide range of respiratory diseases, including respiratory infections such ...


COPD Foundation

Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in the U.S. and the only chronic disease growing in mortality. It affects approximately 24 million Americans but only 12 million are diagnosed. COPD includes chronic bronchitis, emphysema, and adult onset (refractory) asthma. Symptoms include breathlessness, wheezing, and chr...

Ascendant Neuro

For the past 15 years, Ascendant Neuro has successfully conducted minimally invasive pain treatment techniques through the innovative use of neurostimulators. Ascendant Neuro's trained physicians, which treat chronic pain of the spine as well as chronic migraine headaches, use neurostimulation to eliminate the symptoms of migraine and chronic head pain.

Vapotherm, Inc

Vapotherm, Inc. is dedicated to the development of unique and advanced technologies for respiratory airway therapies...especially for the treatment of chronic lung and acute breathing disorders.The company focuses on innovative products which allow high flow, non-invasive delivery of respiratory gases...particularly where conventional technologies fail.

PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Intersect ENT, Inc. '

Intersect ENT, Inc. is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets two steroid releasing implants, PROPEL and PROPEL mini, clinically proven to improve surgical outcomes for patients with chronic sinusitis undergoing ethmoid sinus surgery. In addition, Intersect ENT is developing new ste...

Parkinson?s Unity Walk

Parkinson's disease is the second most common chronic neurological disorder in older adults after Alzheimer's, affecting approximately one percent of people over age 60. Approximately 15 percent of patients develop Parkinson's disease before the age of 50. Every nine minutes someone is diagnosed with Parkinson's disease. Symptoms include tremor, muscle rigidity, slowed motion, shuffling gait, and ...

ALung Technologies, Inc.

ALung Technologies, Inc. is commercializing artificial lung devices for the treatment of acute and chronic respiratory disorders. The company's Hemolung System, designed to replace or supplement the use of ventilators for patients with acute respiratory failure, is scheduled to begin clinical trials in the fall of 2009. Learn more about ALung and Hemolung at www.alung.com.

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respiratory Therapists for a diverse range of therapies. RTG Products are distributed in Acute, Sub Acute, Skilled Nursing, Home and Hospice Settings, through our increasing network of d...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Respiratory Health Association of Metropolitan Chicago

Vapotherm, Inc.

Vapotherm, Inc. is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1.7 million patients have been treated with Vapotherm Hi-VNI Techn...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease. Co...

Therabron Therapeutics, Inc.

Therabron Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company’s product candidates aim to restore the natural immune balance in the lungs of respiratory patients through the administr...

Asthma, Allergy & Immunology Clinic

Allergic rhinitis or "hay fever." Symptoms of allergic rhinitis are sneezing, congestion, itching and dripping of the nose, and itchy, watery eyes. There are basically two types of allergic rhinitis: seasonal (for example, during fall, spring, or both) and perennial (year-round). Seasonal allergic rhinitis refers to allergies caused by pollen from trees, grasses, and/or weeds. Perennial allergic r...

NanoCor Therapeutics, Inc.

NanoCor Therapeutics, Inc. ("NanoCor") is a biotechnology company founded to create the first viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure ("CHF"). The company was spun off from Asklepios BioPharmaceutical, Inc. in August 2005.CHF is the end product of a number of cardiovascular diseases that degrade the heart's ability to pump blood efficiently. The Ame...

Propeller Health

Propeller Health is a leading digital health company dedicated to the management of respiratory disease. Propeller creates products to more effectively treat chronic respiratory disease and improve clinical outcomes for patients through connectivity, analytics, and companion digital experiences. The Propeller platform is used by patients, physicians and healthcare organizations in the United Stat...

Palyon Medical

Palyon Medical Corporation, headquartered in Southern California, is a privately held medical device company focused on creating innovative treatment systems to alleviate symptoms of chronic pain, spasticity, diseases of the central nervous system and chronic metabolic diseases. Palyon’s mission is to provide the market with the broadest range of impl...

National Board for Respiratory Care

With the mission of promoting excellence in respiratory care by awarding credentials based on high competency standards, The National Board for Respiratory Care seeks to protect and enhance patient lives. Nearly 30,000 candidates test for the NBRC credentials each year to demonstrate how excellence defines them across seven specific areas of respiratory care. All 49 states regulating the professi...

ResMed Inc.

ResMed (NYSE: RMD) (ASX: RMD), a world-leading connected health company with more than 5 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-m...

Adheris, Inc.

Over the last 80 years, the disease burden imposed on Western nations has shifted from acute life-threatening illnesses to chronic degenerative disorders. Today, the leading causes of morbidity and mortality in the U.S. are chronic diseases such as hypertension, high cholesterol, asthma, and diabetes. The effects of chronic diseases often accumulate slowly over decades. Consequently, the burden o...

Pearl Therapeutics Inc.

Pearl Therapeutics is developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. Leveraging its proprietary particle technology, formulation expertise and unparalleled product development experience, Pearl is rapidly advancing a pipeline of products that offer patients and healthcare professionals ...

American Chronic Pain Association


More From BioPortfolio on "Determine the Association Between the Level of SCI With Chronic Respiratory Symptoms, Measures of Pulmonary Function, and Respiratory Illness."

Quick Search

Corporate Database Quicklinks